Primary tabs

Development of Extremophile Bacteriophage-based Vaccines

Samuel M. Duboise of the University of Southern Maine in the U.S., along with colleagues in Kenya, will develop a vaccine platform that uses bacteriophages that are structurally stable in one of Earth's most extreme environments - the hypersaline alkaline soda lakes of Kenya's Great Rift Valley. Vaccines produced using these engineered bacteriophages are expected to be inexpensive, stable, and easy to produce in regionally dispersed locations using common microbiological and biochemical methods that are highly scalable and adaptable for "just-in-time" production.

Grant ID
OPP1061344
Show on Hub
On
Show on Spoke
On
Follow-on Funding
Off
Lead Funding Organization
Principal Investigator
Individual Funder Information
Funding Organization
Funding Amount (in original currency)
100000.00
Funding Currency
USD
Funding Amount (in USD)
100000.00
Project Primary Sector
Funding Date Range
-
Funding Total (In US dollars)
100000.00
Co-Funded
False